Article

Hypersensitivity for capsaicin in patients with functional dyspepsia.

Abteilung für Gastroenterologie und Hepatologie, Medical University of Vienna, Vienna, Austria.
Neurogastroenterology and Motility (Impact Factor: 3.42). 03/2008; 20(2):125-33. DOI: 10.1111/j.1365-2982.2007.00997.x
Source: PubMed

ABSTRACT The pathophysiology of functional dyspepsia is poorly understood, thus diagnostic and therapeutic options for this disease are limited. We assessed the relevance of a simple test for chemical hypersensitivity by applying an oral capsaicin load. After a preliminary dose-finding study, 61 healthy controls and 54 functional dyspepsia patients swallowed a capsule containing 0.75 mg capsaicin. A graded questionnaire evaluated severity of symptoms before and after capsule ingestion; an aggregate symptom score was calculated by adding all symptom scores. Controls developed moderate symptoms (symptom score: 6.0+/-4.1; median: 5.0). The 75% quartile (9.0) was considered the upper limit of normal. Functional dyspepsia patients had significantly higher symptom scores (10.0+/-6.5) than controls. About 54% of functional dyspepsia patients tested positive; clinically this group was not different from the group testing negative besides being on average younger and suffering more from bloating. In additional 13 patients with functional dyspepsia who tested positive (symptom score: 15.8+/-0.9), symptom response to placebo capsules (1.9+/-0.6) was similar to controls. In reliability testing, the Cronbach alpha-value of the capsaicin test was 0.86. The capsaicin test is a simple and non-invasive method to detect a subgroup of functional dyspepsia with chemical hypersensitivity.

0 Followers
 · 
205 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Die Diagnostik der funktionellen Dyspepsie ist zunächst eine Ausschlussdiagnostik, um andere Erkrankungen die dyspeptische Beschwerden verursachen können zu entdecken. Sind diese durch Anamnese, Basisuntersuchungen und Routinediagnostik hinreichend sicher ausgeschlossen, kann beim Fehlen von Alarmsymptomen als nächster Schritt eine probatorische Therapie erfolgen. Nur bei atypischer Anamnese oder unklaren Symptomen sollte eine weiterführende Diagnostik angestrebt werden. Die Therapieansätze bieten neben dem Einsatz von Phytotherapeutika die Möglichkeit, bei Helicobacter-pylori-Positivität einen Eradikationsversuch zu unternehmen oder eine Säureblockade mit H2-Blockern oder Protonenpumpeninhibitoren durchzuführen. Für diese Ansatzpunkte ist ein positiver Wirknachweis erbracht. Andere Therapieansätze sind entweder noch in der Zulassungsphase oder es gibt für sie bisher noch keine stabilen therapeutischen Ergebnisse.
    Der Gastroenterologe 09/2013; 8(5). DOI:10.1007/s11377-013-0781-3
  • [Show abstract] [Hide abstract]
    ABSTRACT: Dyspepsia is a common gastroenterological problem with an estimated global prevalence between 7 and 40%. Functional dyspepsia (FD) is a major economic burden to patients and healthcare systems and significantly affects patient quality of life. The ROME III definition of FD divides it into two subgroups, epigastric pain syndrome and postprandial distress syndrome, the former being more associated with reflux disease and the latter with gastric dysmotility. The global incidence and prevalence of FD continues to rise, but the reason for this is not clear. Rising global obesity and gastroesophageal reflux disease rates may be contributing to the rise in FD. Socioeconomic and cultural demographic changes such as changing dietary habits and rapid urbanization, particularly in the developing countries, are likely to be influencing the course of FD and the way it presents. © 2014 S. Karger AG, Basel.
    Digestive Diseases 01/2014; 32(3):217-21. DOI:10.1159/000357853 · 1.83 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Functional gastrointestinal disorders (FGID) are common clinical syndromes diagnosed in the absence of biochemical, structural, or metabolic abnormalities. They account for significant morbidity and health care expenditures and are identifiable across variable age, geography, and culture. Etiology of abdominal pain associated FGIDs, including functional dyspepsia (FD), remains incompletely understood, but growing evidence implicates the importance of visceral hypersensitivity and electromechanical dysfunction. This manuscript explores data supporting the role of visceral hypersensitivity and electromechanical dysfunction in FD, with focus on pediatric data when available, and provides a summary of potential therapeutic targets.

Full-text (2 Sources)

Download
7 Downloads
Available from
Nov 8, 2014